Paying Investigators
Biopharmaceutical and medical device companies rely on investigative sites to complete their clinical trials. Building strong relationships with high-quality sites is critical to addressing a number of key challenges – from the growing number of trials to mounting pressures to minimize cycle times. Yet investigative sites increasingly denounce unrealistic payment schedules and inefficient payment processes as not only frustrating but also threatening to their financial viability.
Many sponsors and CROs continue to use standalone spreadsheets and databases to manage grant calculations – increasing financial risk and the probability of error. Because there is no integration with Accounts Payable once a grant is calculated, manual processes are used to provide such data.